Alanamu AS, Abubakar MY, Adeoye MN. Islamic World and Scientific Activity in Historical Perspective. Pakistan J Social Sciences. 2008; 5(4): 341-6.
Bomford A, Williams R. Long term results of venesection therapy in idiopathic haemochromatosis. QJM. 1976; 45(4): 611-23.
Davidson M. The Principles and Practice of Medicine. Postgraduate Medical Journal. 1931; 6(69): 141.
Falize L, Guillygomarc’h A, Perrin M, Lainé F, Guyader D, Brissot P, et al. Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases. Hepatology. 2006; 44(2): 472-7.
Ho C-K, Lee C-W, Lu J, Wu J, Koh W-P, Chan C-Y, et al. New hope for an old cure: a pilot animal study on selective venesection in attenuating the systemic effects of ischaemic-reperfusion injury. Ann Acad Med Singapore. 2009; 38(7): 569-7.
Hy L, Ho H. Performing therapeutic venesection in a doctor’s surgery. Australian family physician. 2017; 46(3): 132-8.
Lippi G, Cervellin G, Mattiuzzi C. Migraine and erythrocyte biology: a review. Int J laboratory hematology. 2014; 36(6): 591-7.
Nagamia HF. Islamic medicine history and current practice. JISHIM. 2003; 2: 19-30.
Nasir A, Fatma G, Ali W, Ahmad MA. Role of Ilaj-Bil-Tadbeer (Regimental Therapy) as Non-Medical Therapy in Unani System of Medicine. European J Pharmaceutical and Medical Research. 2018, 5(2): 213-218.
Parapia LA. History of bloodletting by phlebotomy. British J Haematology. 2008; 143(4): 490-5.
Sherwani AM, Ansari AN, Ansari HA, Ansari IAJA. The Contribution of Albucasis (Abul-Qasim Zahravi) in Venesection. J Int Society History Islamic Medicine (ISHIM). 2004; 3: 6.
Strand T. Evaluation of long-term outcome and safety after hemodilution therapy in acute ischemic stroke. Stroke. 1992; 23(5): 657-62.
Turk J, Allen E. Bleeding and cupping. Annals of the Royal College of Surgeons of England. 1983; 65(2): 128.